Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  EntreMed Inc       US29382F2020

SummaryNewsCalendarCompany 
Business Summary
Develops pharmaceutical drugs for treating cancer & inflammatory diseases

CASI Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company developing a new generation of multi-mechanism drugs for the treatment of cancer and inflammatory diseases.

Its drug candidate, ENMD 2076, which is an Aurora A and angiogenic kinase inhibitor for the treatment of cancer.

The company was founded in 1991 and is headquartered in Rockville, MD.

Number of employees : 16 persons.
Sales per Businesses
20122013Delta
USD (in Million)%USD (in Million)%
Therapeutics0.669100%---
Sales per Regions
20122013Delta
USD (in Million)%USD (in Million)%
United States0.669100%---
Managers
NameAgeSinceTitle
Ken Keyong Ren MD, PhD552012Chief Executive Officer
Wei-Wu He PhD, MBA492012Executive Chairman
Cynthia Wong Hu442006COO, Secretary, Vice President & General Counsel
Sara B. Capitelli, CPA442011Chief Accounting Officer & Vice President-Finance
William E. Gannon Jr., MD-2012Vice President-Medical & Regulatory Affairs
Jennie C. Hunter-Cevera, PhD662001Independent Director
Tak W. Mak, PhD672012Director
James Z. Huang, MBA482013Independent Director
Yue Alexander Wu PhD, MBA502013Independent Director
Franklin Cary Salisbury, Jr.-2014Director
Shareholders
NameShares%
IDG Capital Partners Co., Ltd. 6,842,78325.3%
Spectrum Pharmaceuticals, Inc. 5,405,38220.0%
Celgene Corp. 2,464,9879.12%
Wellington Shields Capital Management LLC 775,1552.87%
Wellington Shields & Co. LLC 518,5831.92%
Emerging Technology Partners LLC 441,0721.63%
Kleiner Perkins Caufield & Byers LLC 416,6661.54%
The Vanguard Group, Inc. 391,6601.45%
Tak W. Mak, PhD 365,3761.35%
BlackRock Fund Advisors 255,4540.94%
Sector
Healthcare
Pharmaceuticals & Medical Research
 Biotechnology & Medical Research
  Biotechnology & Medical Research
   Biotechnology & Medical Research - NEC
Advertisement
Sector Biotechnology & Medical Research
Growth (Revenue) Profitability
INCYTE CORPORATIO..
PHARMACYCLICS, IN..
ALKERMES PLC
ALNYLAM PHARMACEU..
QUINTILES TRANSNA..
ISIS PHARMACEUTIC..
PUMA BIOTECHNOLOG..
-
UNITED THERAPEUTI..
COVANCE INC.
QIAGEN NV
SEATTLE GENETICS,..
BIO-TECHNE CORP
ACADIA PHARMACEUT..
ICON PLC
SYNAGEVA BIOPHARM..
PAREXEL INTERNATI..
CHARLES RIVER LAB..
BB BIOTECH AG
INTREXON CORP
MORPHOSYS AG
Sector Biotechnology & Medical Research
Company contact information
CASI Pharmaceuticals, Inc.
9620 Medical Center Drive
Suite 300
Rockville, MD 20850

Phone : +1.240.864.2600
Fax : +1.240.315.2437
Web : www.casipharmaceuticals.com
© 2014 Factset   
Dynamic quotes  
ON
| OFF